Predictors of serious arrhythmic events in patients with nonischemic heart failure
- 10 December 2016
- journal article
- research article
- Published by Springer Nature in Journal of Interventional Cardiac Electrophysiology
- Vol. 48 (2) , 131-139
Abstract
Risk stratification of serious arrhythmic events in patients with nonischemic heart failure (HF), beyond estimates of left ventricular ejection fraction (LVEF), remains an important clinical challenge. This study aims to determine the clinical value of different noninvasive and invasive tests as predictors of serious arrhythmic events in patients with nonischemic HF. A prospective observational study was conducted including 106 nonischemic HF patients who underwent a comprehensive clinical and laboratory evaluation including two-dimensional echocardiography, 24-h Holter monitoring, cardiopulmonary exercise testing (CPX), and an invasive electrophysiological study. The study’s primary end-point was either syncope, appropriate therapy by implantable cardioverter-defibrillators, or sudden cardiac death. During a mean follow-up of 704 ± 320 days, the primary end-point occurred in 15 patients (14.2%). In multivariable analysis, LV end-diastolic diameter >73 mm (hazard ratio [HR] 3.7; p = 0.016), exercise periodic breathing (EPB) on CPX (HR 2.88; p = 0.045), and non-sustained ventricular tachycardia (NSVT) ≥10 beats (HR 8.2; p < 0.01) remained independently associated with serious arrhythmic events. The positive predictive value of the presence of two of these predictors ranged from 44 to 100%. The absence of all three factors (n = 65, 61% of the sample) identified a subset of patients with low risk of future arrhythmic events, with a negative predictive value of 96.9%. In this cohort study of nonischemic HF patients, LV dimension, EPB, and NSVT ≥10 beats were independent predictors of serious arrhythmic events. The presence or absence of these characteristics identified sub-groups of high and low risk of serious arrhythmic events, respectively.Keywords
Funding Information
- FIPE-HCPA (Fundo de Incentivo a Pesquisa do Hospital de Clínicas de Porto Alegre) and CNPq
This publication has 21 references indexed in Scilit:
- Defibrillator Implantation in Patients with Nonischemic Systolic Heart FailureNew England Journal of Medicine, 2016
- B-type natriuretic peptide is a major predictor of ventricular tachyarrhythmiasHeart Rhythm, 2014
- The need to modify patient selection to improve the benefits of implantable cardioverter-defibrillator for primary prevention of sudden death in non-ischaemic dilated cardiomyopathyEP Europace, 2013
- Association of Fibrosis With Mortality and Sudden Cardiac Death in Patients With Nonischemic Dilated CardiomyopathyJAMA, 2013
- A meta-analysis of the prognostic significance of cardiopulmonary exercise testing in patients with heart failureHeart Failure Reviews, 2013
- Cost-Effectiveness of Implantable Cardioverter-Defibrillators in Brazil: Primary Prevention Analysis in the Public SectorValue in Health, 2010
- Characteristics, Outcomes, and Predictors of Mortality at 3 Months and 1 Year in Patients Hospitalized for Acute Heart FailureEuropean Journal of Heart Failure, 2010
- Non-Sustained Ventricular Tachycardia as a Predictor of Sudden Cardiac Death in Patients with Left Ventricular Dysfunction: A Meta-AnalysisEuropean Journal of Heart Failure, 2008
- Exercise Oscillatory Ventilation May Predict Sudden Cardiac Death in Heart Failure PatientsJACC, 2007
- Amiodarone or an Implantable Cardioverter–Defibrillator for Congestive Heart FailureNew England Journal of Medicine, 2005